Hepatitis C

Top Story

‘Think outside the box’ to finance HCV elimination

‘Think outside the box’ to finance HCV elimination
November 14, 2017

An important barrier to hepatitis elimination is the upfront costs, which may be subverted with a range of financing mechanisms, according to data from international economic analyses presented at the World Hepatitis Summit 2017.

“The original purpose of the Polaris Observatory was to focus on the disease burden and help national governments know how many people are infected, diagnosed and treated,” Homie A. Razavi, PhD, managing director at the Center for Disease Analysis, Colorado, told Healio.com/Hepatology. “What’s become clear is that financing is a major barrier to achieving the WHO elimination targets, so we’ve been focusing now on how to support countries with financing mechanisms and running economic analyses to see what it will cost to achieve elimination.”

In the Journals

Liver waitlist outcomes for patients with HCV improving in recent years

November 14, 2017
In recent years, mortality rates and progression of disease severity has decreased among patients with hepatitis C on the liver transplant waitlist, according to…
In the Journals

DAAs produce cure rates in HCV/HIV co-infection similar to monoinfection

November 13, 2017
Using direct-acting antiviral therapies demonstrated similarly high rates of sustained virologic response for hepatitis C virus infection in patients with and without…
Editorial

Welcome to the New World Order A Competitive HCV Drug Marketplace

HCV Next, November/December
Michael S. Saag, MD
More Headlines »
Advertisement
Advertisement